Paula Walker

Paula Walker is Quality Policy Lead for Product Development Quality at Roche/Genentech.

Previously Paula had a variety of roles at MHRA, most recently Acting Head of inspectorate. Paula

was a founding member of MHRA’s Innovative Licensing Access Pathway (ILAP) Steering Group,

and sat on the ILAP Board alongside NICE, SMC  Welsh colleagues.

Paula is particularly interested in ATMPs, including as a member of the working group that published

the EC Advanced Therapy Guidelines